Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20350966rdf:typepubmed:Citationlld:pubmed
pubmed-article:20350966lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:20350966lifeskim:mentionsumls-concept:C0026848lld:lifeskim
pubmed-article:20350966lifeskim:mentionsumls-concept:C0240339lld:lifeskim
pubmed-article:20350966lifeskim:mentionsumls-concept:C0020792lld:lifeskim
pubmed-article:20350966lifeskim:mentionsumls-concept:C2347026lld:lifeskim
pubmed-article:20350966lifeskim:mentionsumls-concept:C0370003lld:lifeskim
pubmed-article:20350966lifeskim:mentionsumls-concept:C0017337lld:lifeskim
pubmed-article:20350966lifeskim:mentionsumls-concept:C0026882lld:lifeskim
pubmed-article:20350966lifeskim:mentionsumls-concept:C0015278lld:lifeskim
pubmed-article:20350966lifeskim:mentionsumls-concept:C0017921lld:lifeskim
pubmed-article:20350966lifeskim:mentionsumls-concept:C1314792lld:lifeskim
pubmed-article:20350966lifeskim:mentionsumls-concept:C0220908lld:lifeskim
pubmed-article:20350966lifeskim:mentionsumls-concept:C1414899lld:lifeskim
pubmed-article:20350966lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:20350966lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:20350966pubmed:issue8lld:pubmed
pubmed-article:20350966pubmed:dateCreated2010-7-15lld:pubmed
pubmed-article:20350966pubmed:abstractTextPompe disease or glycogen-storage disease type 2 (GSD2, OMIM 232300) is an autosomal recessive disorder caused by mutations in the acid alpha-glucosidase gene. Late-onset GSD2 resembles some limb-girdle and Becker muscular dystrophies. The screening of GSD2 through the measurement of acid alpha-glucosidase activity in dried blood spots was applied to a selected sample of 5 Mexican patients with proximal myopathies of unknown etiology. Only 1 male patient showed a low level of acid alpha-glucosidase activity and a compound heterozygote genotype for the c.-32-13T>G splicing mutation present in most white late-onset Pompe disease cases and the novel mutation p.C558S. To our knowledge, this is the first report of a Mexican patient with late-onset GSD2. The identification of c.-32-13T>G in our patient could reflect the genetic contribution of European ancestry to the Mexican population. The enzymatic screening of GSD2 could be justified in patients with myopathies of unknown etiology.lld:pubmed
pubmed-article:20350966pubmed:languageenglld:pubmed
pubmed-article:20350966pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20350966pubmed:citationSubsetIMlld:pubmed
pubmed-article:20350966pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20350966pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20350966pubmed:statusMEDLINElld:pubmed
pubmed-article:20350966pubmed:monthAuglld:pubmed
pubmed-article:20350966pubmed:issn1708-8283lld:pubmed
pubmed-article:20350966pubmed:authorpubmed-author:González-del...lld:pubmed
pubmed-article:20350966pubmed:authorpubmed-author:Alcántara-Ort...lld:pubmed
pubmed-article:20350966pubmed:authorpubmed-author:Barrientos-Rí...lld:pubmed
pubmed-article:20350966pubmed:authorpubmed-author:CupplesCourtn...lld:pubmed
pubmed-article:20350966pubmed:authorpubmed-author:Garrido-Garcí...lld:pubmed
pubmed-article:20350966pubmed:authorpubmed-author:de...lld:pubmed
pubmed-article:20350966pubmed:authorpubmed-author:Alva-ChaireAd...lld:pubmed
pubmed-article:20350966pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20350966pubmed:volume25lld:pubmed
pubmed-article:20350966pubmed:ownerNLMlld:pubmed
pubmed-article:20350966pubmed:authorsCompleteYlld:pubmed
pubmed-article:20350966pubmed:pagination1034-7lld:pubmed
pubmed-article:20350966pubmed:meshHeadingpubmed-meshheading:20350966...lld:pubmed
pubmed-article:20350966pubmed:meshHeadingpubmed-meshheading:20350966...lld:pubmed
pubmed-article:20350966pubmed:meshHeadingpubmed-meshheading:20350966...lld:pubmed
pubmed-article:20350966pubmed:meshHeadingpubmed-meshheading:20350966...lld:pubmed
pubmed-article:20350966pubmed:meshHeadingpubmed-meshheading:20350966...lld:pubmed
pubmed-article:20350966pubmed:meshHeadingpubmed-meshheading:20350966...lld:pubmed
pubmed-article:20350966pubmed:meshHeadingpubmed-meshheading:20350966...lld:pubmed
pubmed-article:20350966pubmed:meshHeadingpubmed-meshheading:20350966...lld:pubmed
pubmed-article:20350966pubmed:meshHeadingpubmed-meshheading:20350966...lld:pubmed
pubmed-article:20350966pubmed:meshHeadingpubmed-meshheading:20350966...lld:pubmed
pubmed-article:20350966pubmed:meshHeadingpubmed-meshheading:20350966...lld:pubmed
pubmed-article:20350966pubmed:meshHeadingpubmed-meshheading:20350966...lld:pubmed
pubmed-article:20350966pubmed:meshHeadingpubmed-meshheading:20350966...lld:pubmed
pubmed-article:20350966pubmed:meshHeadingpubmed-meshheading:20350966...lld:pubmed
pubmed-article:20350966pubmed:year2010lld:pubmed
pubmed-article:20350966pubmed:articleTitleScreening of late-onset Pompe disease in a sample of Mexican patients with myopathies of unknown etiology: identification of a novel mutation in the acid alpha-glucosidase gene.lld:pubmed
pubmed-article:20350966pubmed:affiliationLaboratorio de Biología Molecular, Departamento de Genética Humana, Instituto Nacional de Pediatría, México. malcantaraortigoza@gmail.comlld:pubmed
pubmed-article:20350966pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20350966pubmed:publicationTypeCase Reportslld:pubmed
entrez-gene:2548entrezgene:pubmedpubmed-article:20350966lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:20350966lld:entrezgene